Research spans natural product‑inspired medicinal chemistry and antimicrobial discovery, integrating cell‑based screening, hit‑to‑lead optimization, structure–activity relationships, target identification, and scalable synthesis/peptide ligation to deliver fast‑acting small molecules and peptide therapeutics for drug‑resistant infections.